Ascendis Pharma A/S - ASND
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 11, 2026 | SCHEDULE 13G/A | Westfield Capital Management Company, L.P. | 8.48% | 5,185,696 | View |
| Feb 03, 2026 | SCHEDULE 13G/A | Artisan Partners Asset Management Inc. | 5.2% | 3,225,885 | View |
| Feb 03, 2026 | SCHEDULE 13G/A | Artisan Partners Holdings LP | 5.2% | 3,225,885 | View |
| Feb 03, 2026 | SCHEDULE 13G/A | Artisan Investments GP LLC | 5.2% | 3,225,885 | View |
| Feb 03, 2026 | SCHEDULE 13G/A | Artisan Partners Limited Partnership | 5.2% | 3,225,885 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | T. Rowe Price Investment Management, Inc. | 4.8% | 2,667,563 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 7.8% | 4,323,059 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.